Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care Unit

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

May 13, 2023

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions
Stress Ulcer
Interventions
BEHAVIORAL

To evaluate the effectiveness and safety of a pharmacist-driven protocol to discontinue stress ulcer prophylaxis in ICU patients when it is no longer indicated according to pre-defined criteria.

"To evaluate the effectiveness and safety of a pharmacist-driven protocol to discontinue stress ulcer prophylaxis in ICU patients when it is no longer indicated according to pre-defined criteria.~To compare the incidence of overt GI bleeds (defined as hematemesis, bloody nasogastric tube aspirate, or melena) between patients who were on stress ulcer prophylaxis versus patients whose acid suppression therapy was discontinued through the stress ulcer prophylaxis minimization protocol."

Trial Locations (1)

75082

Methodist Richardson Medical Center, Richardson

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT06225167 - Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care Unit | Biotech Hunter | Biotech Hunter